We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2016:HKEXChina Zheshang Bank Co., Ltd Analysis

Data as of 2026-03-14 - not real-time

HK$2.62

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

China Zheshang Bank (2016.HK) trades at a trailing PE of about 4.5, far below the industry average of 16.3, and a price‑to‑book of 0.36, suggesting a substantial valuation discount. The stock offers an attractive dividend yield of 6.5%, but the sustainability is questionable given negative operating cash flow and a high debt load. Technical signals are mixed: price sits just above a key support around 2.56 HKD, while the MACD histogram is bearish and the 20‑day SMA (2.64) sits below the 50‑day SMA (2.56), indicating limited short‑term momentum. Volatility over the past 30 days is roughly 16% and beta is very low, implying limited price swings relative to the market but also highlighting potential illiquidity. Recent material news reports approval for a $1 billion IPO, which could inject capital and improve the balance sheet, providing a catalyst for upside. Overall, the stock appears undervalued with a strong dividend appeal, yet faces risks from cash‑flow weakness, regulatory scrutiny in China’s banking sector, and uncertain dividend sustainability.
The medium‑term outlook is brighter if the IPO proceeds and the bank can stabilize cash generation, offering a potential upside of about 25% from current levels. Investors should weigh the low valuation and dividend income against the high debt, negative cash flow, and medium‑level sector and regulatory risks before deciding on entry timing.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support level with limited upside momentum
  • Bearish MACD signal
  • Negative operating cash flow raising near‑term concerns

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount (PE 4.5 vs industry 16.3)
  • High dividend yield of 6.5%
  • Potential capital infusion from approved $1 bn IPO

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Uncertainty over dividend sustainability due to cash‑flow deficits
  • Elevated regulatory and geographic risk in Chinese banking
  • Long‑term upside potential if balance sheet improves post‑IPO

Key Metrics & Analysis

Financial Health

Revenue Growth-8.80%
Profit Margin36.64%
P/E Ratio4.5
ROE7.16%
ROA0.44%
P/B Ratio0.4
Op. Cash FlowHK$-79004000256
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI51.7
SupportHK$2.56
ResistanceHK$2.69
MA 20HK$2.64
MA 50HK$2.56
MA 200HK$2.70
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target PriceHK$3.27
Upside/Downside24.82%
GradeUndervalued
TypeValue
Dividend Yield6.50%

Risk Assessment

Beta0.06
Volatility16.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.